Mellar P. Davis

16.9k total citations · 1 hit paper
289 papers, 11.6k citations indexed

About

Mellar P. Davis is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Anesthesiology and Pain Medicine. According to data from OpenAlex, Mellar P. Davis has authored 289 papers receiving a total of 11.6k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Public Health, Environmental and Occupational Health, 87 papers in Pediatrics, Perinatology and Child Health and 76 papers in Anesthesiology and Pain Medicine. Recurrent topics in Mellar P. Davis's work include Pain Management and Opioid Use (69 papers), Palliative Care and End-of-Life Issues (67 papers) and Cancer survivorship and care (41 papers). Mellar P. Davis is often cited by papers focused on Pain Management and Opioid Use (69 papers), Palliative Care and End-of-Life Issues (67 papers) and Cancer survivorship and care (41 papers). Mellar P. Davis collaborates with scholars based in United States, Australia and Italy. Mellar P. Davis's co-authors include Declan Walsh, Susan B. LeGrand, Ruth Lagman, Éduardo Bruera, Florian Strasser, Stein Kaasa, Aminah Jatoi, Charles L. Loprinzi, Lukas Radbruch and Faith D. Ottery and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Mellar P. Davis

266 papers receiving 11.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Definition and classification of cancer cachexia: an international consensus

2011 4.0k citations Éduardo Bruera, Charles L. Loprinzi et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mellar P. Davis United States	52	4.9k	2.9k	2.5k	2.4k	1.7k	289	11.6k
Declan Walsh United States	59	5.8k 1.2×	4.5k 1.6×	3.4k 1.4×	3.6k 1.5×	2.5k 1.5×	348	15.8k
Marie Fallon United Kingdom	48	3.0k 0.6×	3.3k 1.2×	1.3k 0.5×	1.8k 0.8×	1.6k 0.9×	248	9.9k
Andrew Wilcock United Kingdom	35	4.0k 0.8×	1.6k 0.6×	858 0.3×	954 0.4×	906 0.5×	138	7.3k
Judith A. Paice United States	50	1.9k 0.4×	3.9k 1.3×	4.4k 1.8×	3.8k 1.6×	1.8k 1.1×	219	12.1k
Kenneth C. H. Fearon United Kingdom	57	7.5k 1.5×	4.0k 1.4×	593 0.2×	757 0.3×	8.2k 4.9×	113	16.4k
Sebastiano Mercadante Italy	61	3.6k 0.7×	2.0k 0.7×	3.8k 1.5×	5.9k 2.5×	4.3k 2.5×	448	14.6k
Andrew Moore United Kingdom	59	5.9k 1.2×	784 0.3×	1.3k 0.5×	1.4k 0.6×	3.2k 1.9×	194	14.4k
Pål Klepstad Norway	45	1.3k 0.3×	1.1k 0.4×	1.0k 0.4×	2.1k 0.9×	1.2k 0.7×	225	6.7k
Per Sjøgren Denmark	48	1.5k 0.3×	1.3k 0.5×	2.7k 1.1×	2.0k 0.8×	1.1k 0.6×	222	7.5k
Franco De Conno Italy	46	1.7k 0.3×	1.4k 0.5×	2.8k 1.1×	3.3k 1.4×	1.9k 1.1×	134	8.3k

Countries citing papers authored by Mellar P. Davis

Since Specialization

Citations

This map shows the geographic impact of Mellar P. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mellar P. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mellar P. Davis more than expected).

Fields of papers citing papers by Mellar P. Davis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mellar P. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mellar P. Davis. The network helps show where Mellar P. Davis may publish in the future.

Co-authorship network of co-authors of Mellar P. Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Mellar P. Davis. A scholar is included among the top collaborators of Mellar P. Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mellar P. Davis. Mellar P. Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Davis, Mellar P., et al.. (2026). Biased Kappa-opioid Agonist Strategies in Pain Management: Approaches to Clinical Benefits with Reduced Adverse Effects. Drugs. 86(2). 161–175.

George, Naomi, et al.. (2025). Successful Treatment of Intractable Hiccups With Methylphenidate in a Colon Cancer Patient. Journal of Pain and Symptom Management. 69(5). e633–e633.

Davis, Mellar P.. (2025). Buprenorphine Pharmacodynamics: A Bridge to Understanding Buprenorphine Clinical Benefits. Drugs. 85(2). 215–230. 3 indexed citations

Davis, Mellar P., A. Ulrich, Rebecca Segal, et al.. (2024). Treatment of Established Chemotherapy-Induced Neuropathy with N-Palmitoylethanolamide: A Randomized, Double-Blind Phase II Pilot Study. Cancers. 16(24). 4244–4244.

Davis, Mellar P., et al.. (2024). State-level variation in distribution of oxycodone and opioid-related deaths from 2000 to 2021: an ecological study of ARCOS and CDC WONDER data in the USA. BMJ Open. 14(3). e073765–e073765. 4 indexed citations

Davis, Mellar P., Andrew Davies, Mary Lynn McPherson, et al.. (2024). Correction to: Opioid analgesic dose and route conversion ratio studies: a scoping review to inform an eDelphi guideline. Supportive Care in Cancer. 32(9). 596–596. 1 indexed citations

Davis, Mellar P., et al.. (2023). Radiation Therapy in the Last Month of Life: Association With Aggressive Care at the End of Life. Journal of Pain and Symptom Management. 66(6). 638–646. 1 indexed citations

Chwistek, Marcin, et al.. (2023). Should Buprenorphine Be Considered a First-Line Opioid for the Treatment of Moderate to Severe Cancer Pain?. Journal of Pain and Symptom Management. 66(5). e638–e643. 6 indexed citations

Feo, Giulia De, Amy A. Case, Gregory B. Crawford, et al.. (2023). Multinational Association of Supportive Care in Cancer (MASCC) guidelines: cannabis for psychological symptoms including insomnia, anxiety, and depression. Supportive Care in Cancer. 31(3). 176–176. 13 indexed citations

10.

Weimer, Melissa B., Mellar P. Davis, Katie Fitzgerald Jones, et al.. (2022). Top Ten Tips Palliative Care Clinicians Should Know About Buprenorphine. Journal of Palliative Medicine. 26(1). 120–130. 13 indexed citations

11.

Reddy, Akhila, Christian T. Sinclair, Gregory B. Crawford, et al.. (2022). Opioid Rotation and Conversion Ratios Used by Palliative Care Professionals: An International Survey. Journal of Palliative Medicine. 25(10). 1557–1562. 6 indexed citations

12.

Hui, David, Sandip Mukhopadhyay, Carole Bouleuc, et al.. (2022). Multinational Association of Supportive Care in Cancer (MASCC) expert opinion/consensus guidance on the use of cannabinoids for gastrointestinal symptoms in patients with cancer. Supportive Care in Cancer. 31(1). 39–39. 17 indexed citations

13.

Davis, Mellar P.. (2020). I Cannot Distance. Journal of Palliative Medicine. 23(11). 1544–1544.

14.

Davis, Mellar P., et al.. (2020). Nonantipsychotics/Nonbenzodiazepines in the Management of Agitated Delirium #397. Journal of Palliative Medicine. 23(8). 1127–1129. 1 indexed citations

15.

Davis, Mellar P.. (2017). PC-FACS. Journal of Pain and Symptom Management. 55(1). 172–178. 1 indexed citations

16.

Davis, Mellar P. & Harold W. Goforth. (2014). Long-term and Short-term Effects of Insomnia in Cancer and Effective Interventions. The Cancer Journal. 20(5). 330–344. 59 indexed citations

17.

Shaheen, Philip, Susan B. LeGrand, Declan Walsh, et al.. (2010). Errors in Opioid Prescribing: A Prospective Survey in Cancer Pain. Journal of Pain and Symptom Management. 39(4). 702–711. 29 indexed citations

18.

Davis, Mellar P.. (2010). Opioid receptor targeting ligands for pain management: a review and update. Expert Opinion on Drug Discovery. 5(10). 1007–1022. 14 indexed citations

19.

Kraut, Eric H., Stanley P. Balcerzak, Donn C. Young, Mellar P. Davis, & Samuel A. Jacobs. (2002). A Phase II Study of Topotecan in Non-Hodgkin's Lymphoma: An Ohio State University Phase II Research Consortium Study. Cancer Investigation. 20(2). 174–179. 8 indexed citations

20.

Allen, Ace, et al.. (1992). Phase II evaluation of piroxantrone in renal cell carcinoma. Investigational New Drugs. 10(2). 129–132. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact